Selected article for: "chloroquine therapy and severe pneumonia"
Author: Zhichao Feng; Jennifer Li; Shanhu Yao; Qizhi Yu; Wenming Zhou; Xiaowen Mao; Huiling Li; Wendi Kang; Xin Ouyang; Ji Mei; Qiuhua Zeng; Jincai Liu; Xiaoqian Ma; Pengfei Rong; Wei Wang
Title: The Use of Adjuvant Therapy in Preventing Progression to Severe Pneumonia in Patients with Coronavirus Disease 2019: A Multicenter Data Analysis
  • Document date: 2020_4_10
    • ID: k65501xp_3
    Snippet: CONCLUSIONS AND RELEVANCE Hypertensive patients on ACEI or ARB may be protective from severe pneumonia in COVID-19 and hence these therapies should not be ceased unless there is a strong indication or further epidemiological evidence. Though none of the current antiviral and immunoregulation therapy showed benefit in preventing COVID-19 progression, chloroquine deserved further investigation......
    Document: CONCLUSIONS AND RELEVANCE Hypertensive patients on ACEI or ARB may be protective from severe pneumonia in COVID-19 and hence these therapies should not be ceased unless there is a strong indication or further epidemiological evidence. Though none of the current antiviral and immunoregulation therapy showed benefit in preventing COVID-19 progression, chloroquine deserved further investigation.

    Search related documents:
    Co phrase search for related documents
    • current immunoregulation antiviral therapy and epidemiological evidence: 1
    • current immunoregulation antiviral therapy and epidemiological evidence strong indication: 1
    • current immunoregulation antiviral therapy and immunoregulation antiviral: 1
    • current immunoregulation antiviral therapy and immunoregulation antiviral therapy: 1
    • current immunoregulation antiviral therapy and progression prevent: 1
    • current immunoregulation antiviral therapy and severe pneumonia: 1
    • current immunoregulation antiviral therapy and strong indication: 1
    • epidemiological evidence and immunoregulation antiviral: 1
    • epidemiological evidence and immunoregulation antiviral therapy: 1
    • epidemiological evidence and progression prevent: 1, 2
    • epidemiological evidence and severe pneumonia: 1, 2, 3, 4
    • epidemiological evidence and strong indication: 1
    • epidemiological evidence strong indication and immunoregulation antiviral: 1
    • epidemiological evidence strong indication and immunoregulation antiviral therapy: 1
    • epidemiological evidence strong indication and progression prevent: 1
    • epidemiological evidence strong indication and severe pneumonia: 1
    • epidemiological evidence strong indication and strong indication: 1
    • immunoregulation antiviral and investigation deserve: 1
    • immunoregulation antiviral and progression prevent: 1